Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Chubb
Harvard Business School
Queensland Health
McKinsey
Federal Trade Commission
US Army
Mallinckrodt
Fuji
Cantor Fitzgerald

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 085161

« Back to Dashboard

NDA 085161 describes PREDNISONE, which is a drug marketed by West-ward Pharms Int, Wockhardt, Actavis Labs Fl Inc, Am Therap, Amneal Pharms Ny, Aurolife Pharma Llc, Bundy, Chartwell Rx, Contract Pharmacal, Duramed Pharms Barr, Elkins Sinn, Everylife, Ferrante, Halsey, Heather, Hikma Pharms, Impax Labs, Inwood Labs, Ivax Sub Teva Pharms, Jubilant Cadista, Kv Pharm, Lannett, Lederle, Marshall Pharma, Mutual Pharm, Mylan Pharms Inc, Nylos, Panray, Pharmavite, Phoenix Labs Ny, Purepac Pharm, Pvt Form, Rexall, Roxane, Sandoz, Scherer Labs, Sperti, Sun Pharm Industries, Superpharm, Teva, UDL, Upsher Smith, Valeant Pharm Intl, Vangard, Vintage Pharms, Vitarine, Watson Labs, and Whiteworth Town Plsn, and is included in one hundred and seven NDAs. It is available from fifty-nine suppliers. Additional details are available on the PREDNISONE profile page.

The generic ingredient in PREDNISONE is prednisone. There are sixteen drug master file entries for this compound. Sixty suppliers are listed for this compound. Additional details are available on the prednisone profile page.
Summary for 085161
Tradename:PREDNISONE
Applicant:Watson Labs
Ingredient:prednisone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 085161
Suppliers and Packaging for NDA: 085161
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PREDNISONE prednisone TABLET;ORAL 085161 ANDA Actavis Pharma, Inc. 0591-5443 N 0591-5443-05
PREDNISONE prednisone TABLET;ORAL 085161 ANDA Actavis Pharma, Inc. 0591-5443 N 0591-5443-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
McKinsey
Boehringer Ingelheim
Dow
Argus Health
Cantor Fitzgerald
Covington
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot